Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003302 · ClinicalTrials.gov registry record · NA
MRI to Detect Breast Tumors in Women
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 1,500
- Enrollment target
NCT00003302: Completed NA study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT00003302 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 1,500 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003302, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,500 participants
- Enrollment target
Study Summary
RATIONALE: New imaging procedures, such as MRI, may improve the ability to detect breast tumors. PURPOSE: Diagnostic study to determine the value of MRI in detecting breast tumors in women who have had suspicious mammographic or clinical examinations.
Interventions
- PROCEDURE biopsy
- DIAGNOSTIC_TEST magnetic resonance imaging
- DIAGNOSTIC_TEST mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 1998-05 |
| Est. Completion | 2000-06-30 |
| Phase | NA |
What the finished NCT00003302 record still lists
NCT00003302 is an interventional study that assigns participants to a tested intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which biopsy is the first listed.
NCT00003302 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003302 about?
NCT00003302 is a clinical study titled "MRI to Detect Breast Tumors in Women". RATIONALE: New imaging procedures, such as MRI, may improve the ability to detect breast tumors. PURPOSE: Diagnostic study to determine the value of MRI in detecting breast tumors in women who have had suspicious mammographic or clinical examinations.
What is the current status of trial NCT00003302?
This trial is currently completed. It is a NA study. The enrollment target is 1,500 participants. The study started on 1998-05. Estimated completion is 2000-06-30.
What interventions are being tested in trial NCT00003302?
The interventions under investigation include: biopsy (PROCEDURE), magnetic resonance imaging (DIAGNOSTIC_TEST), mammography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00003302?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00003302's enrollment target sits among peer trials
1,500 65th of 2000 higher than 1,933 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia